RxDoctor Payments Data

Benjamin Wilson, MD

Family Medicine · Lexington, NCNPI 1235154501

Payments from drug & device makers

$782in general payments, 2019–2025

Across 41 payments — averaging $19.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$123
  • Johnson & Johnson Surgical Vision, Inc.$121
  • Astellas Pharma US Inc$67
  • Amgen$60
  • Novo Nordisk$50
  • Pfizer$50
  • plus $311 from 11 others

What the payments were for

  • Food & beverage$782100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$782 in reported general payments places this provider in the 65th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$73,213
Medicare patients
164
Services billed
1,129

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide118$106,172
EliquisApixaban80$77,477
MounjaroTirzepatide24$25,334
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog22$23,955
XareltoRivaroxaban22$22,009
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$20,482
MyrbetriqMirabegron17$19,453
JanuviaSitagliptin Phosphate26$16,187
LivaloPitavastatin Calcium16$12,494
Incruse ElliptaUmeclidinium Bromide27$12,415
TopamaxTopiramate12$12,092
FarxigaDapagliflozin Propanediol11$11,854
Stiolto RespimatTiotropium Br/Olodaterol Hcl16$11,573
Xtampza ErOxycodone Myristate16$11,009
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen232$7,007

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$50$106,172118 claims
PfizerEliquis$50$77,47780 claims
GSKTrelegy Ellipta, Incruse Ellipta, Anoro Ellipta, Arnuity Ellipta$48$42,56075 claims
Astellas Pharma US IncMyrbetriq$67$19,45317 claims
AstraZenecaFarxiga, Symbicort$123$16,84129 claims
MerckJanuvia$35$16,18726 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Lexington

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →